Asthma is a common long term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath.
As of 2011, 235–330 million people worldwide are affected by asthma, and approximately 250,000–345,000 people die per year from the disease. Rates vary between countries with prevalences between 1 and 18%. It is more common in developed than developing countries.
Propeller Health is a company currently based in the U.S, that wants to help people head off asthma attacks and other respiratory conditions before they get to the point of not being able to breath by watching every breath they take.
This leading digital solution for respiratory medicine, today announced the closing of its $21.5 million Series C financing. The funding round includes new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, and existing investors Safeguard Scientifics and Social Capital. Proceeds will be used to expand Propeller’s digitally-guided therapy platform and modernize the management of respiratory disease.
According to the CEO, David Van Sickle, “We aim to make today’s treatments more accessible, personal, powerful and convenient for each person who uses them, and enable physicians to measure, analyze and act to help their patients.”
“Our goal is to connect and guide these patient-physician teams to find the right path of therapy for each individual.”
Propeller which launched in 2010 is out to modernize respiratory medicine, empower people to minimize the impact of asthma and COPD on their daily lives, and connect them to their physicians, environment and community. Propeller’s information-powered approach to respiratory management guides physicians and patients to the optimal path of therapy for each individual. With connected inhalers, digital interfaces, and real time personalized insights, participants receive personal guidance and expert direction anytime.
They have decided to furnish the medical sector with their innovation and I must say big ups to them. It is highly acknowledged. My only wish is for them to feature the African continent in their expansion plan, and help lots of people suffering respiratory diseases over here.
Its good to see technology taken to the next level and helping people. What do you think about this innovation?
Image credits; techcrunch.com